Teleflex Forecasts 15.9% Q4 Revenue Growth, Shares Up 7.3% Last Month
Teleflex delivered Q3 revenues of $892.9 million, up 16.8% year-on-year, and analysts forecast 15.9% revenue growth for Q4 after matching last quarter’s EPS estimates. Shares have risen 7.3% over the past month versus a 1.9% peer group decline, with an average price target of $129.25 compared to the current $112.12.
1. Q3 Financial Recap
Teleflex reported third-quarter revenues of $892.9 million, marking a 16.8% increase year-on-year and beating analysts’ EPS estimates for the period.
2. Q4 Revenue and EPS Estimates
Analysts expect fourth-quarter revenue to grow 15.9% year-on-year, up from a 2.8% increase in the same quarter last year, with EPS forecasts largely unchanged over the past 30 days.
3. Peer Comparison and Stock Performance
Intuitive Surgical delivered 18.8% year-on-year revenue growth and Envista posted 15% growth, while Teleflex shares have climbed 7.3% over the past month versus a 1.9% decline across its healthcare equipment peer group; the average analyst price target stands at $129.25 compared with the current $112.12 share price.
4. Projections for Key Metrics
Analysts have also provided projections for key metrics such as operating margin, free cash flow and organic volume growth to assess underlying business performance in the quarter ended December 2025.